Stouten Pharma Consultancy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Stouten Pharma Consultancy
Largest movements
- Cash +€98,949
up €98,949 (+70.3%), from €140,757 to €239,706
mainly Net result for the year (+€57,915) and Receivables within one year (+€35,467)
- Receivables within one year -€35,467
down €35,467 (-96.1%), from €36,890 to €1,423
of which Trade receivables: -€35,289
- Reserves +€55,415
up €55,415 (+48.8%), from €113,522 to €168,937
- Tax, wage and social debts +€21,453
up €21,453 (+46.9%), from €45,741 to €67,194
of which Taxes: +€21,453
- Contributions -€18,000
down €18,000 (-90.0%), from €20,000 to €2,000
- Profit (loss) carried forward +€2,500
new in 2025: €2,500
- Gross operating margin -€78,343
down €78,343 (-49.1%), from €159,450 to €81,107
- Taxes -€24,288
down €24,288 (-53.1%), from €45,741 to €21,453
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €180,444 | €242,184 | +€61,739 | +34.2% |
| Fixed assets | 21/28 | €2,017 | €603 | -€1,415 | -70.1% |
| Tangible fixed assets | 22/27 | €2,017 | €603 | -€1,415 | -70.1% |
| Plant, machinery and equipment | 23 | €2,017 | €603 | -€1,415 | -70.1% |
| Current assets | 29/58 | €178,427 | €241,581 | +€63,154 | +35.4% |
| Amounts receivable within one year | 40/41 | €36,890 | €1,423 | -€35,467 | -96.1% |
| Trade receivables | 40 | €36,373 | €1,084 | -€35,289 | -97.0% |
| Other amounts receivable | 41 | €517 | €338 | -€178 | -34.5% |
| Cash at bank and in hand | 54/58 | €140,757 | €239,706 | +€98,949 | +70.3% |
| Deferred charges and accrued income | 490/1 | €780 | €452 | -€328 | -42.1% |
| Total equity and liabilities | 10/49 | €180,444 | €242,184 | +€61,739 | +34.2% |
| Equity | 10/15 | €133,522 | €173,437 | +€39,915 | +29.9% |
| Contributions | 10/11 | €20,000 | €2,000 | -€18,000 | -90.0% |
| Reserves | 13 | €113,522 | €168,937 | +€55,415 | +48.8% |
| Distributable reserves | 133 | €113,522 | €168,937 | +€55,415 | +48.8% |
| Profit (loss) carried forward | 14 | - | €2,500 | +€2,500 | |
| Amounts payable | 17/49 | €46,922 | €68,747 | +€21,824 | +46.5% |
| Amounts payable within one year | 42/48 | €46,922 | €68,747 | +€21,824 | +46.5% |
| Financial debts | 43 | €364 | €0 | -€364 | -100% |
| Other loans | 439 | €364 | €0 | -€364 | -100% |
| Trade debts | 44 | €202 | €914 | +€713 | +353% |
| Suppliers | 440/4 | €202 | €914 | +€713 | +353% |
| Taxes, remuneration and social security | 45 | €45,741 | €67,194 | +€21,453 | +46.9% |
| Taxes | 450/3 | €45,741 | €67,194 | +€21,453 | +46.9% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €615 | €638 | +€23 | +3.7% |
| Non-recurring operating income | 76A | - | €1,623 | +€1,623 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,415 | €1,415 | = | 0.0% |
| Other operating charges | 640/8 | €182 | €285 | +€103 | +56.6% |
| Gross operating margin | 9900 | €159,450 | €81,107 | -€78,343 | -49.1% |
| Operating profit (loss) | 9901 | €157,854 | €79,408 | -€78,446 | -49.7% |
| Financial income | 75/76B | €0 | €2 | +€2 | |
| Recurring financial income | 75 | €0 | €2 | +€2 | |
| Financial charges | 65/66B | €55 | €42 | -€14 | -24.6% |
| Recurring financial charges | 65 | €55 | €42 | -€14 | -24.6% |
| Profit (loss) for the period before taxes | 9903 | €157,799 | €79,368 | -€78,431 | -49.7% |
| Income taxes | 67/77 | €45,741 | €21,453 | -€24,288 | -53.1% |
| Profit (loss) for the period | 9904 | €112,058 | €57,915 | -€54,143 | -48.3% |
| Profit (loss) for the period to be appropriated | 9905 | €112,058 | €57,915 | -€54,143 | -48.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.